MOA Life Plus Co. Ltd. (KOSDAQ: 142760)

South Korea flag South Korea · Delayed Price · Currency is KRW
1,282.00
-5.00 (-0.39%)
Nov 15, 2024, 9:00 AM KST
-48.51%
Market Cap 49.43B
Revenue (ttm) 18.44B
Net Income (ttm) 5.63B
Shares Out 37.73M
EPS (ttm) 174.21
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 51,202
Open 1,271.00
Previous Close 1,287.00
Day's Range 1,255.00 - 1,320.00
52-Week Range 1,248.00 - 4,500.00
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Nov 13, 2024

About MOA Life Plus

MOA Life Plus Co. Ltd. engages in the medicine and consumer business in South Korea. It offers P53, a target anti-cancer drug. The company’s pipeline products include BLS-H01, which is in phase 3 clinical trial for the treatment of cervical cancer; BLC-H03, a vaccine adjuvant that is in preclinical stage; BLS-M07 that has completed phase 2b clinical trial for the treatment of cervical cancer; and BLS-M22 that has completed phase 1 clinical trial for the treatment of Duchenne muscular dystrophy. It also provides health functional food and raw ma... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 1999
Employees 49
Stock Exchange KOSDAQ
Ticker Symbol 142760
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.